Obesity Management Market Size, Share, Competitive Landscape, and Trend Analysis Report by Type, Diet, Application, End User, and Region: Global Opportunity Analysis and Industry Forecast, 2024-2033

The obesity management market was valued at $138.19 billion in 2023 and is estimated to reach $350.34 billion by 2033, exhibiting a CAGR of 9.9% from 2024 to 2033.

Overview of Obesity Management

Obesity management is essential for treating obesity-related hypertension. Reducing fat burden lowers blood pressure, enhances antihypertensive medication efficacy, and positively impacts other cardiac risk factors while preventing or delaying type 2 diabetes. Weight loss and adopting a healthy lifestyle are fundamental in managing obese hypertensive patients and are globally applicable. Clinicians must collaborate with patients to motivate, educate, and guide the patients, developing a personalized plan considering their health status, goals, and unique challenges. Sustained weight loss typically necessitates a multidisciplinary team, including dietitians, nurses, nurse practitioners, physician assistants, and access to psychologists and exercise physiologists. This comprehensive approach ensures that patients receive the support needed for long-term success.

Key Takeaways

• The obesity management market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
• More than 1,500 product literatures, industry releases, annual reports, and other such documents of major obesity management industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
• The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

Industry Trends

• In December 2023, Welldoc, a digital health company revolutionizing chronic care, expanded its platform to include weight management support. Their comprehensive chronic care platform now covers prediabetes, diabetes, hypertension, heart failure, and weight management, along with integrated mental wellbeing and sleep apnea support. As part of Welldoc’s total health approach, AI-driven, personalized digital coaching is available 24/7. This helps individuals manage their weight, whether they are starting with lifestyle changes or are prescribed a GLP-1 medication. Welldoc’s platform aims to provide continuous, advanced support across multiple chronic conditions.
• In August 2023, Novo Nordisk agreed to acquire Inversago Pharma, a private Montreal-based company, for up to $1.075 billion contingent on achieving specific development and commercial milestones. Inversago specializes in CB1 receptor-based therapies aimed at treating obesity, diabetes, and metabolic disorder complications. Their leading asset, INV-202, is an oral CB1 inverse agonist designed to selectively block the CB1 receptor protein in peripheral tissues, including the gastrointestinal tract, adipose tissues, liver, kidneys, muscles, pancreas, and lungs, thereby playing a crucial role in metabolism and appetite regulation.

Key Market Dynamics

Government initiatives aimed at raising awareness about weight management are pivotal in driving the growth of obesity management. By implementing campaigns, educational programs, and policies, authorities are effectively addressing this public health concern. For instance, the weight management health note app, by the Korean Society for the Study of Obesity (KSSO), aids in weight management and promotes well-being. Designed to individual needs, it offers tools and resources for effective weight control, emphasizing complete health improvement. The initiatives promoting healthy eating habits and regular physical activity lead to a reduction in obesity rates. Such efforts not only inform individuals about the risks associated with obesity but also empower them with the knowledge and resources to make healthier lifestyle choices. Consequently, an increase in government-led initiatives promotes a favorable environment for tackling obesity on a broader scale.

Moreover, obesity management faces hurdles due to a lack of sustainable solutions and challenges with compliance. Despite efforts, long-term effectiveness remains uncertain, impeding progress. Compliance issues further compound the problem, hindering individuals' ability to adhere to treatment plans consistently. These obstacles, deeply entrenched in the landscape of obesity management, demand innovative approaches for lasting impact. Without effective strategies addressing both long-term sustainability and compliance, efforts to combat obesity may struggle to yield significant results. Overcoming these hurdles necessitates a multifaceted approach, integrating behavioral interventions, and societal support.

However, the increasing number of digital programs dedicated to promoting healthy lifestyles signals a positive growth for obesity management. With technology evolving rapidly, these programs offer personalized solutions to combat the global health challenge of obesity. By harnessing the power of digital platforms, individuals can access advanced guidance, nutritional advice, and exercise routines conveniently. This trend signifies a shift towards proactive health management, empowering people to take control of their well-being. As these digital initiatives continue to increase, they are poised to significantly contribute to the growth and efficacy of obesity management efforts in the years to come.

Public Policy Analysis

Obesity management public policies play a crucial role in controlling obesity rates. One significant approach includes framing policies aimed at controlling obesity. These policies often encompass a range of strategies, such as promoting healthier eating habits, encouraging physical activity, and providing education about the risks associated with obesity. One of the significant policies for obesity management is given below:

Epidemiology and Genomics Research Program (EGRP):

In order to support grant proposals filed in response to funding opportunities, EGRP collaborates with other NCI Divisions, Offices, and Centers as well as other Institutes and Centers at the National Institutes of Health (NIH). Additionally, investigator-initiated funding applications on subjects connected to policy research on obesity are encouraged by EGRP.

EGRP's Risk Factor Assessment Branch (RFAB) supports various initiatives in obesity policy research:

• Promoting research on diet and physical activity that may inform policymaking at local, state, or federal levels
• Measurement of the food and physical activity environments
• Searchable database of diet and physical activity measures relevant to childhood obesity research and user guides to provide an overview of measurement and present case studies to guide how to select appropriate measures (in collaboration with the National Collaborative on Childhood Obesity Research)

Obesity Policy Resources

• Classification of Laws Associated with School Students (C.L.A.S.S.)

A tool created by the NCI's Division of Cancer Control and Population Sciences' Behavioral Research Program to offer policy classification systems for the state's surroundings related to school nutrition, physical education, and recess

• Dietary Assessment Research Resources

A compilation of links to sites for gathering data, analyzing diets, and tracking the American diet, such as the National Collaborative on Childhood Obesity Research (NCCOR) Measures Registry and the Dietary Assessment Primer from EGRP

• Nutrition Evidence Systematic Review (NESR)

Specializing in performing systematic reviews pertaining to food and nutrition and employing a rigorous and transparent system for evaluating, synthesizing, and grading research to characterize the state of food and nutrition-related science

Market Segmentation

The obesity management market is segmented into type, diet, application, end user, and region. On the basis of type, the market is divided into equipment, services, and supplements. As per diet, the market is segregated into meals, beverages, and nutraceuticals. Based on application, the market is divided into body shaping, weight maintenance, aesthetic procedures, sports injuries, chronic wound management, and others. On the basis of end user, the market is categorized into consulting services and commercial weight loss centers, fitness centers and health clubs, online weight loss programs, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Country Market Outlook

The rising rates of obesity across Pacific nations, notably New Zealand and Australia, signal a concerning demand for proper guidance to control obesity in the coming years. As these countries observe an increase in obese population, there is a surging necessity for obesity management strategies from healthcare professionals. The challenges posed by obesity extend beyond individual health concerns to encompass broader societal and economic impacts. Addressing this issue demands multifaceted approaches, spanning education, healthcare policies, and community interventions. Failure to curb this trend could intensify healthcare burdens and diminish overall well-being. Therefore, proactive measures must be undertaken to implement effective obesity management programs designed to the unique cultural and social contexts of these nations.

In June 2023, Sino Biopharmaceutical Ltd. Entered into a collaboration with Gmax Biopharm International Ltd. to advance the obesity treatment candidate GMA-106. This partnership, valued at $57 million, grants Sino Biopharm the exclusive rights for developing and marketing the drug in Greater China. As part of the agreement, Sino Biopharm would make upfront payments and milestone-based compensations to Gmax Biopharm. The deal highlights Sino Biopharm's strategic expansion efforts and signifies Gmax Biopharm's confidence in the potential of GMA-106 as a promising solution for addressing obesity.

Competitive Landscape

The major players operating in the obesity management market include Herbalife Ltd., Eli Lilly and Company, Johnson Health Tech, Roche Holding AG, Nestle SA, Abbott Laboratories, The Kellogg Company, eDiets, Inc., Olympus Corporation, and Brunswick Corporation. Other players in the obesity management market include Glanbia PLC, and Weight Watchers International, Inc.

Recent Key Strategies and Developments

• In December 2023, AbbVie's $8.7 billion acquisition of Cerevel Therapeutics from Cambridge, Mass., enhanced its neuroscience portfolio with clinical-stage and preclinical drugs. The highlight is emraclidine, a late-stage next-gen antipsychotic, promising for schizophrenia treatment. AbbVie eyes its potential in dementia-related psychosis linked to Alzheimer's and Parkinson's. Meanwhile, Roche's $2.7 billion purchase of Carmot Therapeutics in Berkeley, Calif., signals its venture into weight-loss treatments. With an additional $400 million in milestone payments possible, Roche aims to establish itself in this burgeoning field, potentially revolutionizing weight management therapies.
• In March 2023, WeightWatchers, in a strategic move, finalized the acquisition of telehealth platform Weekend Health, known as Sequence, for $106 million. Sequence, renowned for its telehealth consultations and comprehensive services encompassing insurance coordination, nutrition, and fitness plans, also offers crucial glucagon-like peptide-1 medications such as semaglutide, marketed under the brand names Wegovy, Ozempic, and Rybelsus. Founded in 2021, Sequence boasted approximately 24,000 members as of February. This acquisition signals WeightWatchers' intent to broaden its health-focused offerings, integrating telehealth services and pharmaceutical options.

Key Sources Referred

1. The Obesity Society
2. World Obesity Federation
3. European Association for the Study of Obesity
4. Novo Nordisk
5. Eli Lilly and Company
6. Roche Holding AG
7. WeightWatchers

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the obesity management market segments, current trends, estimations, and dynamics of the obesity management market analysis from 2023 to 2033 to identify the prevailing obesity management market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the obesity management market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global obesity management market statistics.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global obesity management market trends, key players, market segments, application areas, and market growth strategies.

The market study comprises of all latest technological advancements, including the latest market development by major players operating in the market. Furthermore, the study also comprises detailed public policy analysis.